Teva Pharmaceutical Industries Limited (NYSE:TEVA) is in talks to sell Migda at an estimated valuation of $80 million. The deal is being conducted against the background of demands by the Migda union that the buyer commit not to move the factory for at least five years. The three potential buyers are Fresenius Medical Care AG & Co.

KGaA (XTRA:FME), B. Braun Melsungen AG and Maabarot Products Ltd. (TASE:MABR).